Skip to main content

Title 19 Promis's Form 4 filing

ProMIS Neurosciences Inc. (PMN) · filed Aug 2, 2024

Accession no.
0001104659-24-085375
Filed
Aug 2, 2024
Trade date
Jul 31, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Title 19 PromisCIK 000200553110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 31, 2024Common Shares, no par valuePPurchaseAcquired+465,116––1,575,629DirectDuplicate filing
Jul 31, 2024Common Shares, no par valueCConversionAcquired+500,000––2,075,629DirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 31, 2024Common SharesPPurchaseAcquired+465,116––465,116DirectDuplicate filing
Jul 31, 2024Common SharesPPurchaseAcquired+465,116––465,116DirectDuplicate filing
Jul 31, 2024Common SharesPPurchaseAcquired+465,116––465,116DirectDuplicate filing
Jul 31, 2024Common SharesCConversionDisposed−500,000––0DirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)